HW

Howard Welgus

AM Amgen: 3 patents #987 of 2,867Top 35%
VP Verrica Pharmaceuticals: 3 patents #5 of 13Top 40%
WC Warner-Lambert Company: 3 patents #488 of 1,610Top 35%
AB Arcutis Biotherapeutics: 1 patents #6 of 11Top 55%
Overall (All Time): #433,007 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
12290651 Devices and methods for the treatment of body surface disorders Matthew Gene Davidson, Jayson M. Rieger, Eugene Scavola, Paul Daly 2025-05-06
12233042 Treatment of cutaneous disorders Matthew Gene Davidson, Jayson M. Rieger 2025-02-25
11992480 Method for reducing side effects from administration of phosphodiesterase-4 inhibitors David W. Osborne 2024-05-28
11865113 Methods of treating a patient afflicted with non-alcoholic steatohepatitis (NASH) Nigel R. A. Beeley, J. Gordon Foulkes, Kieran George Mooney, Charles Rodney Greenaway Evans, Keith Johnson +1 more 2024-01-09
11147790 Treatment of cutaneous disorders Matthew Gene Davidson, Jayson M. Rieger 2021-10-19
7189747 Method of treating noninflammatory cartilage damage Denis Schrier, David Juergen Wustrow 2007-03-13
6800732 Human collagenase inhibitor, recombinant vector system for using same and recombinant DNA method for the manufacture of same David F. Carmichael, David C. Anderson, George P. Stricklin 2004-10-05
6620829 Method of treating noninflammatory cartilage damage Denis Schrier, David Juergen Wustrow 2003-09-16
6342374 Human collagenase inhibitor, recombinant vector system for using same and recombinant-DNA method for the manufacture of same David F. Carmichael, David C. Anderson, George P. Stricklin 2002-01-29
6211209 Method of inhibiting connective tissue degradation Vijaykumar Baragi, Diane H. Boschelli, David T. Connor, Richard Raymond Renkiewicz 2001-04-03
6090585 Human collagenase inhibitor sequence, recombinant vector system for using same and recombinant-DNA method for the manufacture of same David F. Carmichael, David C. Anderson, George P. Stricklin 2000-07-18